HOMOCAMPTOTHECIN

ID: ALA74190

Max Phase: Preclinical

Molecular Formula: C21H18N2O4

Molecular Weight: 362.39

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Homocamptothecin
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1

    Standard InChI:  InChI=1S/C21H18N2O4/c1-2-21(26)9-18(24)27-11-14-15(21)8-17-19-13(10-23(17)20(14)25)7-12-5-3-4-6-16(12)22-19/h3-8,26H,2,9-11H2,1H3/t21-/m1/s1

    Standard InChI Key:  PAEZRCINULFAGO-OAQYLSRUSA-N

    Associated Targets(Human)

    DNA topoisomerase I 7553 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HT-29 80576 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    A549 127892 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    T-24 2342 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    NCI-H460 60772 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 362.39Molecular Weight (Monoisotopic): 362.1267AlogP: 2.47#Rotatable Bonds: 1
    Polar Surface Area: 81.42Molecular Species: NEUTRALHBA: 6HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 13.81CX Basic pKa: 3.08CX LogP: 1.15CX LogD: 1.15
    Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: 0.90

    References

    1. Lavergne O, Demarquay D, Bailly C, Lanco C, Rolland A, Huchet M, Coulomb H, Muller N, Baroggi N, Camara J, Le Breton C, Manginot E, Cazaux JB, Bigg DC..  (2000)  Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins.,  43  (11): [PMID:10841808] [10.1021/jm000129j]
    2. Lavergne O, Lesueur-Ginot L, Pla Rodas F, Kasprzyk PG, Pommier J, Demarquay D, Prévost G, Ulibarri G, Rolland A, Schiano-Liberatore AM, Harnett J, Pons D, Camara J, Bigg DC..  (1998)  Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.,  41  (27): [PMID:9876111] [10.1021/jm980400l]
    3. Giannini G, Marzi M, Cabri W, Marastoni E, Battistuzzi G, Vesci L, Pisano C, Beretta GL, De Cesare M, Zunino F..  (2008)  E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation.,  18  (9): [PMID:18424133] [10.1016/j.bmcl.2008.03.074]
    4. Huang Q, Wang L, Lu W..  (2013)  Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.,  63  [PMID:23578545] [10.1016/j.ejmech.2013.01.058]

    Source